Intest Res Search

CLOSE


Search

  • HOME
  • Search
Use of device-assisted enteroscopy in small bowel disease: an expert consensus statement by the Korean Association for the Study of Intestinal Diseases
Han Hee Lee, Jin Su Kim, Hyeon Jeong Goong, Shin Hee Lee, Eun Hye Oh, Jihye Park, Min Cheol Kim, Kwangwoo Nam, Young Joo Yang, Tae Jun Kim, Seung-Joo Nam, Hee Seok Moon, Jae Hyun Kim, Duk Hwan Kim, Seong-Eun Kim, Seong Ran Jeon, Seung-Jae Myung, The Small Intestine Research Group of the Korean Association for the Study of Intestinal Diseases (KASID)
Intest Res. 2023;21(1):3-19.   Published online January 31, 2023
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Anti-inflammatory properties of butyrate-producing atypical Escherichia coli in a murine colitis model
Ji Hyung Kim, Jee In Yoo, Hyun Woo Ma, I Seul Park, Mijeong Son, Yoojin Shin, Ki Beom Kim, Seung Won Kim, Si Jae Park, Jihye Park
Received September 6, 2022  Accepted September 22, 2022  
DOI: https://doi.org/10.5217/ir.2022.00112    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Close layer
prev next
Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?
Jihye Park
Intest Res. 2022;20(1):1-2.   Published online January 26, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model
Jihye Park, Da Hye Kim, Soochan Kim, Hyun Woo Ma, I Seul Park, Mijeong Son, Ji Hyung Kim, Yoojin Shin, Seung Won Kim, Jae Hee Cheon
Intest Res. 2021;19(4):478-481.   Published online October 26, 2021
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Miscellaneous
Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience
Jihye Park, Jae Hee Cheon, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim
Intest Res. 2018;16(2):315-318.   Published online April 30, 2018
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
Jihye Park, Jae Hee Cheon
Intest Res. 2017;15(3):263-265.   Published online June 12, 2017
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD


ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2023 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next